JCI - Citations to HIV-1 protease inhibitors and the MDR1 multidrug transporter.

Citations to this article

HIV-1 protease inhibitors and the MDR1 multidrug transporter.

C G Lee, M M Gottesman

C G Lee, M M Gottesman

Published January 15, 1998
Citation Information: J Clin Invest. 1998;101(2):287-288. https://doi.org/10.1172/JCI2575.

View: Text | PDF

Total citations by year

Year:	2024	2023	2016	2015	2014	2012	2011	2009	2008	2007	2006	2004	2003	2002	2001	2000	1999	1998	Total
Citations:	1	1	3	2	1	3	2	10	4	4	3	8	5	5	5	2	5	1	65

Citation information

Citations to this article (65)

Title and authors	Publication	Year
Tetrandrine for Targeting Therapy Resistance in Cancer Lima EN, Lamichhane S, KC P, Ferreira ES, Koul S, Koul HK	Current topics in medicinal chemistry	2024
Harnessing small extracellular vesicles for pro-oxidant delivery: novel approach for drug-sensitive and resistant cancer therapy. Kang C, Ren X, Lee D, Ramesh R, Nimmo S, Yang-Hartwich Y, Kim D	Journal of Controlled Release	2023
Does the Clearance of Inhaled 99m Tc-Sestamibi Correlate with Multidrug Resistance Protein 1 Expression in the Human Lung? HK Mohan, T Routledge, P Cane, L Livieratos, JR Ballinger, AM Peters	Radiology	2016
Past, Present, and Future Drug Delivery Systems for Antiretrovirals AR Kirtane, R Langer, G Traverso	Journal of Pharmaceutical Sciences	2016
Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents MW Jann, SR Penzak, LJ Cohen		2016
Sirolimus-loaded polymeric micelles with honokiol for oral delivery: Oral micellar delivery system X Li, X Hou, W Ding, S Cong, Y Zhang, M Chen, Y Meng, J Lei, Y Liu, G Li	Journal of Pharmacy and Pharmacology	2015
Changing Patterns in the Neuropathogenesis of HIV During the HAART Era T. D. Langford, S. L. Letendre, G. J. Larrea, E. Masliah	Brain Pathology	2015
Expression of breast cancer resistance protein in peripheral T cell subsets from HIV-1-infected patients with antiretroviral therapy JC Zhang, ZY Deng, Y Wang, F XIE, LI Sun, FA Zhang	Molecular medicine reports	2014
Cancer Epigenetics RG Dumitrescu, M Verma	Cancer Epigenetics	2012
Cancer Epigenetics RG Dumitrescu, M Verma	Cancer Epigenetics	2012
Cancer Epigenetics RG Dumitrescu, M Verma	Cancer Epigenetics	2012
Human immunodeficiency virus therapeutics and pharmacogenomics U Shankarkumar, A Shankarkumar, K Ghosh	Indian journal of human genetics	2011
Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats JH Park, JH Park, HJ Hur, JS Woo, HJ Lee	European Journal of Pharmaceutical Sciences	2011
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Multi-Drug Resistance in Cancer J Zhou		2009
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors. Hulgan T, Donahue JP, Smeaton L, Pu M, Wang H, Lederman MM, Smith K, Valdez H, Pilcher C, Haas DW	European Journal of Clinical Pharmacology	2009
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs KS Rao, MK Reddy, JL Horning, V Labhasetwar	Biomaterials	2008
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers Q Ma, A Forrest, SL Rosenkranz, MF Para, KE Yarasheski, RC Reichman, GD Morse	Biopharmaceutics & Drug Disposition	2008
Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy O Turriziani, N Gianotti, F Falasca, A Boni, AR Vestri, A Zoccoli, A Lazzarin, G Antonelli	Journal of Medical Virology	2008
Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): Evasion of MRP-2 mediated efflux R Jain, S Agarwal, NK Mandava, Y Sheng, AK Mitra	International Journal of Pharmaceutics	2008
Transporter-mediated drug interactions: clinical implications andin vitroassessment JH Lin	Expert Opinion on Drug Metabolism & Toxicology	2007
No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients DT Petrova, P Nedeva, S Maslyankov, S Toshev, N Yaramov, S Atanasova, D Toncheva, M Oellerich, N Ahsen	Journal of Cancer Research and Clinical Oncology	2007
Principles of Clinical Pharmacology CS Stika, MC Frederiksen	Principles of Clinical Pharmacology	2007
No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients DT Petrova, P Nedeva, S Maslyankov, S Toshev, N Yaramov, S Atanasova, D Toncheva, M Oellerich, N von Ahsen	Journal of Cancer Research and Clinical Oncology	2007
Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids AM Wasilewska, WM Zoch-Zwierz, M Pietruczuk	European Journal of Pediatrics	2006
Human genetic variability and HIV treatment response DW Haas	Current HIV/AIDS Reports	2006
Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition S Dey	Expert Opinion on Drug Delivery	2006
Antiretroviral and immunosuppressive drug-drug interactions: An update H Izzedine, V Launay-Vacher, A Baumelou, G Deray	Kidney International	2004
Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus C Csajka, C Marzolini, K Fattinger, LA Décosterd, A Telenti, J Biollaz, T Buclin	Antimicrobial agents and chemotherapy	2004
Pharmacogenomics of antiretroviral therapy DW Haas	Drug Development Research	2004
P-glycoprotein in autoimmune diseases Y Richaud-Patin, E Soto-Vega, J Jakez-Ocampo, L Llorente	Autoimmunity Reviews	2004
Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients Y Richaud-Patin, F Vega-Boada, A Vidaller, L Llorente	Biomedicine & Pharmacotherapy	2004
Analysis of MDR1 haplotypes in Parkinson's disease in a white population E Tan, M Drozdzik, M Bialecka, K Honczarenko, G Klodowskaduda, Y Teo, K Tang, L Wong, S Chong, C Tan	Neuroscience Letters	2004
Blood-Spinal Cord and Brain Barriers in Health and Disease E Anderson, L Ryan, H Xiong, S Swindells, J Zheng, HE Gendelman	Blood-Spinal Cord and Brain Barriers in Health and Disease	2004
Genomic evidence for recent positive selection at the human MDR1 gene locus K Tang, LP Wong, EJ Lee, SS Chong, CG Lee	Human Molecular Genetics	2004
Drug–drug interaction mediated by inhibition and induction of P-glycoprotein JH Lin	Advanced Drug Delivery Reviews	2003
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitors P Bossi, O Legrand, AM Faussat, M Legrand, F Bricaire, JP Marie, H Agut, B Diquet, C Katlama, JM Huraux, V Calvez	HIV Medicine	2003
A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets J Ford, PG Hoggard, A Owen, SH Khoo, DJ Back	Journal of Immunological Methods	2003
Changing patterns in the neuropathogenesis of HIV during the HAART era T D Langford, S L Letendre, G J Larrea, E Masliah	Brain Pathology	2003
Implications of T-Cell P-Glycoprotein Activity During HIV-1 Infection and Its Therapy: T Hulgan, JP Donahue, C Hawkins, D Unutmaz, RT D'Aquila, S Raffanti, F Nicotera, P Rebeiro, H Erdem, M Rueff, DW Haas	Journal of acquired immune deficiency syndromes (1999)	2003
P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin F Luciani, A Molinari, F Lozupone, A Calcabrini, L Lugini, A Stringaro, P Puddu, G Arancia, M Cianfriglia, S Fais	Blood	2002
Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease AK Ghosh, E Pretzer, H Cho, KA Hussain, N Düzgüneş	Antiviral Research	2002
Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations K Tang, SM Ngoi, PC Gwee, JM Chua, EJ Lee, SS Chong, CG Lee	Pharmacogenetics	2002
MECHANISMS OFCANCERDRUGRESISTANCE MM Gottesman	Annual Review of Medicine	2002
Cell Culture Models of Biological Barriers: In vitro Test Systems for Drug Absorption and Delivery G Fricker, HJ Galla, H Franke	Cell Culture Models of Biological Barriers: In vitro Test Systems for Drug Absorption and Delivery	2002
Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir BM Sadler, C Gillotin, Y Lou, JJ Eron, W Lang, R Haubrich, DS Stein	Antimicrobial agents and chemotherapy	2001
Polymorphisms in the ABC drug transporter gene MDR1 U Brinkmann, M Eichelbaum	The Pharmacogenomics Journal	2001
ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2 R Kerb, S Hoffmeyer, U Brinkmann	Pharmacogenomics	2001
Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy U Brinkmann, I Roots, M Eichelbaum	Drug Discovery Today	2001
HIV-Protease Inhibitors Contribute to P-Glycoprotein Efflux Function Defect in Peripheral Blood Lymphocytes From HIV-Positive Patients Receiving HAART MB Lucia, S Rutella, G Leone, S Vella, R Cauda	JAIDS Journal of Acquired Immune Deficiency Syndromes	2001
Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture MD Perloff, LL von Moltke, JM Fahey, JP Daily, DJ Greenblatt	AIDS	2000
Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter CG Lee, M Ramachandra, KT Jeang, MA Martin, I Pastan, MM Gottesman	The FASEB Journal	2000
Role of pharmacokinetics in the discovery and development of indinavir JH Lin	Advanced Drug Delivery Reviews	1999
Valspodar: current status and perspectives F Loor	Expert Opinion on Investigational Drugs	1999
P-Glycoprotein, a gatekeeper in the blood–brain barrier AH Schinkel	Advanced Drug Delivery Reviews	1999
Molecular dissection of the human multidrug resistance P-glycoprotein TW Loo, DM Clarke	Biochemistry and Cell Biology	1999
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER 1 SV Ambudkar, S Dey, CA Hrycyna, M Ramachandra, I Pastan, MM Gottesman	Annual Review of Pharmacology and Toxicology	1999
Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters RV Srinivas, D Middlemas, P Flynn, A Fridland	Antimicrobial agents and chemotherapy	1998

Advertisement